Institutional Ownership
Omega Therapeutics Inc
CUSIP 68217N105COMMON STOCKQ1 2026
13D / 13G Filings
12
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
52.8%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
12 filings · latest Mar 7, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 7, 2025 | Fmr LLC | 13G/A | — | — | SEC |
| 2 | Feb 5, 2025 | Flagship V Venturelabs Rx Fund, L.P. | 13D/A | 52.8% | — | SEC |
| 3 | Dec 31, 2024 | Flagship V Venturelabs Rx Fund, L.P. | 13D/A | 52.8% | — | SEC |
| 4 | Feb 12, 2024 | Fmr LLC | 13G/A | 10.7% | — | SEC |
| 5 | Feb 9, 2024 | Harbourvest Partners L.P. | 13G/A | 6.4% | 3.51M | SEC |
| 6 | Feb 9, 2024 | Fmr LLC | 13G/A | 9.6% | — | SEC |
| 7 | Mar 10, 2023 | Fmr LLC | 13G/A | 10.1% | — | SEC |
| 8 | Feb 27, 2023 | Flagship Ventures Fund V, L.P. | 13D/A | 2.0% | 1.09M | SEC |
| 9 | Feb 9, 2023 | Fmr LLC | 13G/A | 9.6% | — | SEC |
| 10 | Feb 14, 2022 | Harbourvest Partners L.P. | 13G | 5.5% | 2.65M | SEC |
2 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Omega Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 1 | $0 |